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Abstract
This paper reviews evidence in the context of current research linking dietary fructose to health risk markers.
Fructose intake has recently received considerable media attention, most of which has been negative. The
assertion has been that dietary fructose is less satiating and more lipogenic than other sugars. However, no fully
relevant data have been presented to account for a direct link between dietary fructose intake and health risk mar-
kers such as obesity, triglyceride accumulation and insulin resistance in humans. First: a re-evaluation of published
epidemiological studies concerning the consumption of dietary fructose or mainly high fructose corn syrup shows
that most of such studies have been cross-sectional or based on passive inaccurate surveillance, especially in chil-
dren and adolescents, and thus have not established direct causal links. Second: research evidence of the short or
acute term satiating power or increasing food intake after fructose consumption as compared to that resulting
from normal patterns of sugar consumption, such as sucrose, remains inconclusive. Third: the results of longer-term
intervention studies depend mainly on the type of sugar used for comparison. Typically aspartame, glucose, or
sucrose is used and no negative effects are found when sucrose is used as a control group.
Negative conclusions have been drawn from studies in rodents or in humans attempting to elucidate the
mechanisms and biological pathways underlying fructose consumption by using unrealistically high fructose
amounts.
The issue of dietary fructose and health is linked to the quantity consumed, which is the same issue for any
macro- or micro nutrients. It has been considered that moderate fructose consumption of ≤50g/day or ~10% of
energy has no deleterious effect on lipid and glucose control and of ≤100g/day does not influence body weight.
No fully relevant data account for a direct link between moderate dietary fructose intake and health risk markers.
Introduction
Fructose, a natural sugar found in many fruits, is con-
sumed in significant amounts in Western diets [1]. In
equal amounts, it is sweeter than glucose or sucrose and
is therefore commonly used as a bulk sweetener.
An increase in high fructose corn syrup, as well as
total fructose, consumption over the past 10 to 20 years
has been linked to a rise in obesity and metabolic disor-
ders [2]. This raises concerns regarding the short and
long term effects of fructose in humans.
Why is fructose of concern?
Fructose has been claimed to be of concern due to sev-
eral factors: First, in the 1980’s, sucrose was replaced to
a large extent, particularly in North America, by high
fructose corn syrup (HFCS) in carbonated beverages.
The intake of soft drinks containing HFCS has risen in
parallel with the epidemic of obesity [3]. Second, dietary
fructose has been implicated in risk factors for cardio-
vascular disease (CVD): 1. Plasma triglycerides (TG) and
VLDL-TG increased following the ingestion of large
quantities of fructose; 2. Fructose intake has been found
to predict LDL particle size in overweight schoolchil-
dren [4]; 3. A positive relationship has been demon-
strated between fructose intake and uric acid levels [5].
Third, the use of fructose as a sweetener has increased.
The third National Health Examination Survey
(NHANES) demonstrated that over 10% of Americans’
daily calories were from fructose [6]. These studies sug-
gest that the relationship between fructose and health
needs re-evaluation.
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Lipogenesis from fructose consumption may theoreti-
cally be greater than that induced after eating other
types of sugars such as glucose and sucrose [7]. But
could this be physiologically true?
Evidence from experimental studies in animals
The evidence of the action of dietary fructose, but not
glucose, on increasing appetite and food intake in acute-
term studies has been derived mainly from experimental
studies in animals. Although glucose and fructose utilize
the same signaling pathway to control food intake, they
act in an inverse manner and have reciprocal effects on
the level of the hypothalamic malonyl-CoA, a key inter-
mediate in the hypothalamic signal cascade that regu-
lates energy balance in animals [8]. When injected into
the cerebroventricles of rats, fructose has been found to
induce increase in food intake via a reduction of
hypothalamic malonyl-CoA levels, whereas similar con-
centrations of injected glucose increased malonyl- CoA
suppressing appetite-agonist and food intake [9]. The
rapid initial steps of central fructose metabolism deplete
hypothalamic ATP level, whereas the slower regulated
steps of glucose metabolism elevate hypothalamic ATP
level. Consistent with its effects on the [ATP]/[AMP]
ratio, fructose increases phosphorylation/activation of
hypothalamic AMP kinase causing phosphorylation/
inactivation of acetyl-CoA carboxylase, whereas glucose
mediates the inverse effects.
The question has been raised as to whether fructose
may induce the same effects if presented in the systemic
circulation and not injected directly in the brain. Conse-
quently, Cha et al [10], demonstrated that when glucose
was administered intra-peritoneally, hence entered the
systemic circulation, it was rapidly metabolized by the
brain, increasing the level of hypothalamic malonyl-Co-
A. Fructose administration, however, had the opposite
effect on malonyl-Co-A and food intake. Such a finding
might appear to set off another alarm bell about the
problems of dietary fructose. However, closer inspection
reveals that the latter study used only 4 mice, which
were injected with a dose of 4g/Kg of body weight, a
dose too large to be considered relevant to human
nutrition. While this paper demonstrated that high
d o s e so ff r u c t o s ea n dg l u c o s ea c t e do nd i f f e r e n tp a t h -
ways, the physiological significance of these results
remains unclear. Fructose ingestion is unlikely to
increase fructose levels in the cerebrospinal fluid, and
plasma fructose levels will never exceed the micromolar
range under physiological conditions. Some authors sug-
gested the uncertainty of these effects [11]. Therefore,
no evidence of cause for health concern could be drawn
from such acute studies in rodents.
T h ee f f e c t so ff r u c t o s eo nb o d yw e i g h tw e r ef u r t h e r
questioned. When rats were fed a high fructose diet
(60%) for 6 months then switched to a high fat diet for
2 weeks, leptin levels increased and a state of leptin
resistance was found prior to increased adiposity and
body weight induced by the high fat diet [12]. However,
in other shorter term studies (3-6 weeks) high fructose
feeding (57% in weight) induced insulin resistance and
hypertriglyceridemia in rats but failed to induce an
increase in body weight [13-15].
Thus, in rodents while excessively high fructose intake
may increase appetite by different mechanisms, its’ effect
on body weight needs long term dietary periods.
Acute studies in humans: fructose, food intake and
satiety
Sugars and sugar sweetened beverages have been
blamed for causing obesity, but the debate has raged for
many years with little resolution [16]. More recently, the
intensity of the debate was fuelled by the hypothesis
that HFCS lead to obesity because fructose bypasses
food intake regulatory system (insulin and leptin) and
favors lipogenesis [17]. It was hypothesized that energy
containing drinks, especially those sweetened with
HFCS promotes energy imbalance and thereby play a
role in the development of obesity. In an acute-term
study [17], 12 normal -weight women consumed meals
containing 55, 30 or 15% of total calories as carbohy-
drate, fat and proteins with 30% of Kcal as either fruc-
tose sweetened or glucose sweetened beverages. As
expected, glucose excursions and insulin secretion were
lower after fructose meals than after glucose ones. This
was associated to a decrease in leptin levels, which is an
expected consequence of lowering insulin levels. It is
important to notice that the reduction in leptin levels
remained within physiological normal levels and fluctu-
ated between: 9 ng/ml during the morning and 19.8 ng/
ml by night. After this acute- term study, following only
one meal, the authors rapidly suggested that because
insulin and leptin (the main regulatory factors of food
intake) were lower after fructose meals; they might
increase caloric intake and ultimately contribute to
weight gain and obesity. Fructose meals should be com-
pared to sucrose the usual sugar and not to glucose
which gives extreme levels.
The question was then raised whether HFCS has dif-
ferent effect on satiety than other isoenergetic drinks as
sucrose or milk; again this question was investigated in
an acute study. In order to have a simple response Soe-
nen and Westerterp [18] compared the satiating effects
of 4800 ml of HFCS, sucrose and milk containing each
1.5 MJ in comparison with a diet drink with no energy.
They measured satiety by a visual analogue scale and by
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concentrations. They concluded that energy balance
consequences were the same between the three isoener-
getic drinks evaluated. Therefore, fructose in term of
satiety is not different from that of usually consumed
sugar and even that of another isocaloric drink (milk).
In another study Akhavan et al [19] aimed to evaluate
whether HFCS in soft drinks is different from sucrose
solutions. They compared solutions containing sucrose,
HFCS, or various ratios of glucose to fructose (G50:F50)
on food intake, average appetite and on plasma concen-
trations of glucose, insulin and ghrelin. Measurements
were taken from base line to 80 minutes only. The
authors of the latter paper concluded that all the solu-
tions tested do not have significantly different effects on
subjective and physiologic measures of satiety at a sub-
sequent meal. Therefore, there is no solid evidence that
sucrose, when consumed in its intact form, would con-
fer any benefits over HFCS, which contains the 2
unbound monosaccharides.
Similarly, in a 24 hour study Stanhope 2008 [20] and
Melanson [21] did not find substantially different effects
between meals with either sucrose or HFCS on 24 hour
plasma glucose, insulin, leptin and ghrelin levels. Even
TG profiles were found to be similar between the two
tests. These responses were found to be intermediate
between the lower responses after the pure fructose
syrup consumption and the higher responses after glu-
cose solution ingestion. There was no difference in food
intake during a meal consumed 50 min later or in the
components of food intake regulatory mechanisms.
Chronic studies in humans
Although acute fructose consumption could not stimu-
late leptin secretion, an increase in fasting leptin levels
was detected after chronic high fructose intake (1 to 4
weeks) in healthy individuals, which may suggest that
high fructose feeding may suppress food intake in the
long term [22]. Another long term study in overweight/
obese humans showed no change in body weight after
10 week-supplementation with glucose or fructose, indi-
cating that the effect of fructose or glucose on food
intake might not differ on long term bases [23].
In a cluster randomized controlled study [24], the
effect of a focused educational intervention program on
carbohydrate sweetened beverage consumption and
overweight was studied using 644 children (7-11 years
old). Children participated in a program designed to
emphasize the consumption of a balanced diet and to
discourage the consumption of sweetened drinks
(mainly by sucrose: glucose/fructose). Sweetened drink
consumption decreased in the intervention group and
increased in the control one. Parallel changes in BMI
occurred in each group, but without any difference
between the two groups. Therefore, no conclusion could
b eg i v e no na p p e t i t eo rb o d yw e i g h te v e ni ff r u c t o s ei s
present as a part of sucrose.
Epidemiological studies
The recent epidemiological study of Vos et al [6] created
new concern in regards to fructose consumption. These
authors analyzed data from the US population who had
participated in the NHANES III study, collected from
1988 to 1994. 21,483 adults and children 2 years of age
or older were included in this study. Investigators found
that fructose consumption had increased to 54.7g/d
(10.2% of total caloric intake), compared to 37 g/d (8%)
of total intake in 1977-1978. The consumption was
highest among adolescents (12-18 years) at 72.8g/d
(12.1% of total calories). They showed that over 10% of
Americans’ daily calories were from fructose [6].
Bray et al [25] suggested that the increase in obesity in
the last 35 years has paralleled the increasing use of
high-fructose corn syrup (HFCS), which first appeared
just before 1970. Current soft drinks and many other
foods are sweetened with this product because it is inex-
pensive and has useful manufacturing properties. The
fructose in HFCS and sugar makes beverages very sweet,
and this sweetness may underlie the relationship
between obesity and soft drink consumption. Indeed in
the United States, HFCS has increasingly replaced
sucrose in many foods and sweetened beverages, a fact
that might appear to strengthen the hypothesis that
there is a relationship between fructose and obesity. The
parallelism between the increase in the consumption of
high fructose corn syrup and dietary fructose and the
rise in obesity over the past 10-20 years, linked fructose
to the rise in obesity and metabolic disorders, mainly in
the United States.
This is not the case in Europe or outside the United
states, where fructose is consumed mainly from sucrose
and fructose consumption is linked mainly to sugar con-
sumption. Moreover, the evidence from metabolism stu-
dies on fructose alone is irrelevant to the HFCS and
weight gain debate. Most of the studies dealing with the
causes of obesity and over-weight have centered on
HFCS [26].
Cross-sectional studies
In a cross sectional study, when correlating the BMI of
the NHANES 1988-1994 cohort to the results of
24 hour dietary recall and one food frequency question-
naire by a multivariate regression model, a positive asso-
ciation was found between consumption of carbonated
soft drinks and the BMI of females [27]. Using a conti-
nuing survey of food intake for individuals (CSFII) in
another cross-sectional study, Forshee et al [28] found
that BMI had a statistically positive relationship with
diet carbonated soft drink consumption for both boys
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cents (12-19 years). Other cross-sectional studies in
American children demonstrated a positive correlation
between soft drinks and BMI [29,30]. When looking at
Pacific Island children living in New Zealand, where
HFCS is very limited, the consumption of sucrose has
been evaluated and correlated to body weight. The
obese children consumed more of all types of food with
no difference between obese and non obese children’s
consumption patterns [30].
Most of the cross-sectional studies included no con-
trols for sedentary behaviors, physical activity, and
energy intake from other sources other than beverages
in the model. Moreover, in these studies BMI and bev-
erage consumption were self-reported and hence subject
to measurements errors. Causal relationship cannot be
made from cross-sectional study design.
In longitudinal epidemiologic studies, such as the
US Growing Up Today Study (GUTS) in a cohort of
more than 10,000 males and females (9-14 years in
1996), authors did not find a correlation between BMI
and snack food consumption, including sugar-sweetened
beverages [31] when controlling for total energy [32]. In
the North Dakota Special Supplemental Nutrition Pro-
gram for Women, Infants, and Children (WIC) [33], no
significant association was detected between any of the
beverages evaluated and BMI. Even in another study
among 30 children aged 6-13 years attending the Cor-
nell Summer Day in 1997 [34], excessive sweetened
drink consumption (>370g/day) did not correlate with
weight gain. Again results of these longitudinal studies
are not conclusive. Most of the positive correlations pre-
sented disappeared when corrected by total energy.
Meta-analysis linking soft drink consumption and
body weight demonstrated conflicting results. One
meta-analysis of 12 studies in children and adolescents
[35] failed to find a positive association between soft
drink consumption and body weight, where as another
meta-analysis dealing with 88 studies found an associa-
tion [36].
Conclusion
The relation between HCFS and obesity has been
derived mainly from epidemiological studies trying to
relate the increase in consumption of dietary fructose
and HFCS on one hand and to the increase in obesity
(see ref [37]. In the epidemiological, cross -sectional and
longitudinal studies, the overall evidence for a positive
correlation between consumption of soft drinks and
overweight is limited. Causal inferences cannot be made
from cross-sectional study designs with values subjected
to measurement error. The interventional acute studies
(24 hours) found that fructose is thought to be asso-
ciated with insufficient secretion of insulin and leptin
and suppression of ghrelin when compared with pure
glucose. Such a difference, however, could not be
demonstrated when HFCS compared with sucrose, the
commonly consumed sweetener. In addition appetite
and energy intake do not differ in the acute-term. There
are no long-term interventional studies investigating the
direct relationship between HFCS and body weight [38],
with the exception of Tordoff et al [39] who compared
the consumption of 4 bottles of soda/day (1135g) as
HFCS or as soda sweetened with aspartame for 3 weeks.
Unsurprisingly, subjects who consumed the HFCS as
extra calories gained more weight than those consuming
the soda with aspartame. There is evidence that body
weight increases when calorie intake is in a positive bal-
ance, regardless of whether this is due to HCFS, fat,
proteins or any other form of calories. Moreover, in a
recent meta-analysis, no significant effect of fructose
consumption could be demonstrated on body weight
with doses ≤ 100g/day in adults [40]. Unfortunately the
recent focus on HFCS has done little to resolve the role
of sugars in contributing to energy imbalance.
Meanwhile, a positive effect of fructose on satiety was
demonstrated in the 1990’s. The group of Rodin et al
[41-43] demonstrated that the intake of 50 g fructose
alone as the sole source of carbohydrate, either in solu-
tion or in the form of puddings 2 hours 25 minutes
before a meal, caused a decrease in appetite and lipid
intake. Therefore, this could even be used as an adjunct
to weight control efforts.
Important points
It is clear that fructose is poorly absorbed from the
digestive tract when it is consumed alone. However,
absorption improves when fructose is consumed in
combination with glucose and amino acids [44]. In addi-
tion, the principal sweetener in soft drinks in the US,
HFCS, is not pure fructose but a mixture of fructose
(55%) and glucose (45%). HFCS is predominately present
as HFCS-55 (55% fructose, 41% glucose, and 4% glucose
polymers) or HFCS-42 (42% fructose, 53% glucose and
5% glucose polymers) [26]. Therefore, the term “high
fructose corn syrup” is not a good descriptor of its com-
position, but the term was mandated to distinguish the
newly developed fructose-containing corn syrup from
traditional all-glucose corn syrups. Factors that may
account for the different effects of fructose alone or a
mixture of fructose and glucose could be its gastroin-
testinal effects and absorption characteristics [45].
It should also be noted that even in a study that
increased further the concerns about fructose intake [4],
which looked at overweight Swiss children, the authors
could not demonstrate any correlation between fructose
intakes and adiposity or any other lipid variables in chil-
dren (cholesterol, triglycerides), with the exception of
LDL particle’s size.
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demic, but there is evidence supporting the possibility
that refined carbohydrates in general could have a con-
tributory role, if not a major one. Very recently, this
problem has been attributed to all added sugars (high-
fructose corn syrup or fruit-juice concentrates), and not
only added fructose [46].
Fructose intake as well as HFCS may be a contributor,
but it’s not the sole problem. Obese subjects consume
too many calories for their activity level, including too
much fat, protein and sugar. It is clear that energy
imbalance for most individuals is caused by energy
intake exceeding expenditure. A dietary solution to obe-
sity remains elusive, but focusing on reducing one food
item is unlikely to succeed[47,48]. Moreover, overweight
and obesity are influenced by many genetic [49-51] and
environmental factors [52]: for instance:
a) promoting water consumption can prevent over-
weight among children in elementary school [53]; b)
habituation on behavioral and physiological responses to
repeated presentations of food [54]; c) addressing speci-
fic eating patterns [55] and d) efforts to reduce fast food
portion size [56].
Whatever the cause of obesity, based on the currently
available evidence, an expert panel formed by the Centre
of Food Nutrition and Agriculture Policy concluded that
HFCS does not appear to contribute to overweight and
obesity any differently than other energy sources [26].
Fructose, lipogenesis and cardiovascular risk
factors
Another concern with fructose intake is that it may
induce hypertriglyceridemia and lipogenesis. Theoreti-
cally, fructose consumption can result in increasing TG
synthesis [57].
Intestinal absorption
fructose is absorbed from the intestine via glucose trans-
porters 5 (GLUT 5), then it diffuses into the blood ves-
sels through GLUT 2 or 5 [58], but mainly by GLUT 2.
Contrary to glucose, fructose absorption from the intest-
inal lumen does not require ATP hydrolysis and is inde-
pendent of sodium absorption, which results in massive
fructose uptake by the liver [59].
Hepatic metabolism (Figure 1)
The hepatic metabolism of fructose differs also greatly
from that of glucose. Contrary, to glucose, fructose is
metabolised exclusively in the liver by fructokinase (Km:
0.5 mM). Glucose, however, tends to be transported to
the liver but could be metabolized anywhere in the body
by glucokinase (Km of hepatic glucokinase: 10mM).
In the liver glucose is first phosphorylated by glucoki-
nase to give glucose-6-phosphate, which is then con-
verted to fructose -6-phosphate, and further to fructose
1,6-bisphosphate. This process is regulated by the rate-
limiting enzyme phosphofructokinase, which in inhibited
Figure 1 Fructose and glucose metabolism in liver cells: After several steps glucose is converted into fructose1,6-bi-phosphate. A reaction
regulated by the rate-limiting enzyme phosphofructokinase, which is inhibited by ATP and citrate. Altogether the conversion of glucose to
pyruvate is regulated by insulin. On the other hand, fructose, is massively taken by the liver, and converted rapidly to triose-phosphate
independently of insulin control and without a feedback by ATP or citrate. A large portion of fructose is converted into glucose which can be
released in the blood or stored as glycogen. A part is converted into lactate. A small portion is converted into fatty acids, which may play an
important role in the development of hypertriglyceridemia and fatty liver.
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verted into pyruvate prior to entry into the Krebs cycle.
The hepatic conversion of glucose to pyruvate is regu-
lated by insulin.
In contrast, the conversion of fructose into triose-
Phosphate is a rapid process independent of insulin.
Fructose bypasses the main regulatory step of glycolysis
(the conversion of glucose-6-phosphate to fructose 1,6-
bisphosphate controlled by phosphofructokinase) and
hence can continuously enter the glycolytic pathway.
This rapidity is due mainly to the low Km of fructoki-
nase for fructose, and the absence of negative feedback
by ATP or citrate [60]. A portion of triose-phosphate
produced from fructose can subsequently be converted
into pyruvate and oxidized into CO2 and water. Another
portion is converted into lactate to be released into the
circulation [61]. The major portion of the triose-phos-
phate produced from fructose is converted into glucose
and glycogen through gluconeogenesis [62]. At the end,
part of the carbons from fructose can be converted to
fatty acids. Simultaneously, fructose inhibits hepatic
lipid oxidation favouring fatty acid reesterification and
VLDL-triglyceride synthesis [63]. Therefore, fructose can
rapidly and without any control produce glucose, glyco-
gen, lactate, and pyruvate, providing both the glycerol
and acyl portion of acyl-glycerol molecules. These parti-
cular substrates and the lack of regulation of this path-
way could result in large amounts of TG that can be
packed into very-low density lipoproteins by the liver.
It is essential to note that the general disposition of
fructose carbon between its major end products is mod-
ified by nutritional and endocrine status [64]. Once fruc-
tose has been catabolized to three-carbon molecules its
subsequent metabolic fate is identical to that of glucose.
Hence, fructose can also be converted to glycogen once
a positive energy balance has been established. On the
other hand, glucose is mainly stored as glycogen in the
liver, but high glucose levels may increase formation of
glycerol -3 phosphate and accelerate hepatic triglyceride
production [65].
TG Clearance
Moreover, as VLDL goes into the bloodstream, these
TG can be hydrolyzed by lipoprotein lipase (LPL) into
non-estrified fatty acids and monoacylglycerol. These
components could be taken by adipose tissue to re-
synthesise TG. However, fructose consumption does not
lead to insulin stimulation resulting then in low insulin
excursions that may affect LPL-stimulated lipolysis and
thus contribute to reduced TG clearance. Therefore,
fructose consumption has been suggested to induce
both increased hepatic TG that can be packed into very-
low density lipoproteins by the liver and reduced TG
clearance by adipose tissue.
Intestinal origin of TG
Fructose-induced hyperlipidemia has been also hypothe-
sized to be of intestinal origin. Jeppesen et al [66]
demonstrated that the addition of 50 g fructose to an
oral fat load (40 g) resulted in higher postprandial con-
centrations of triglycerides and retinyl palmitate in
plasma and lipoprotein fraction (of intestinal origin).
These results were found to be more pronounced with
high fasting plasma triglyceride concentrations. The
increase in plasma TG induced by high fructose diet in
hamsters, was demonstrated to originate from fructose
conversion into fatty acids within the enterocytes, with
overproduction of apoB-48-containing lipoprotein
[67,68].
Evidence from experimental studies in animals
Evidence of fructose induced lipogenesis comes mainly
from studies in rodents [69,70]. In fact, evidence exists
that consuming large amounts of fructose leads to the
development of a complete metabolic syndrome in
rodents [71-73].
In the liver, the ability to metabolize fructose more
rapidly than glucose into different metabolites has been
demonstrated in rats [74]. The ratio of fructose metabo-
lism/glucose metabolism (F/G) varies between a mini-
mum of 3 for lactic acid, pyruvic acid, CO2 and free
fatty acids, and a maximum of 19 for glyceraldehyde-
glycerol.
On the other hand, it has been demonstrated that
feeding rats with 75% (w/w) fructose or glucose diets
increased the capacity for triglyceride formation from
glycerol-3-phosphate by rat liver homogenates and
increased incorporation of [1,3-14C] glycerol into
hepatic TG by the intact animal [65]. Hepatic TG pro-
duction changed with a similar time-course character-
istic for each diet. However, the 75% fructose diet
produced a greater increase in both determinations,
reaching a maximum after 11 days. Despite the
increase in hepatic TG formation by both high-sugar
diets, only the 75% fructose diet resulted in a consis-
tent and sustained increase in serum TG. These results
were suggested to be due to differences in the frac-
tional rate of serum TG removal between the two
groups. The authors proposed that high glucose intake
most likely produces an early acceleration in the frac-
tional rate of TG removal that fully compensates for
any increased production, which could be related to
increased insulin stimulated-adipose tissue lipoprotein
lipase activity [75] and accelerated adipose tissue lipo-
genesis [76-78]. This is not the case with fructose,
which does not stimulate insulin secretion.
Studies dealing with mechanisms underlying fructose-
induced lipogenesis provided sufficient evidence in ani-
mals [79]. Enzymes implicated in hepatic lipogenesis
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days on 60% fructose diet [80] induced an increase in
hepatic sterol regulatory element binding protein
(SREBP-1) expression, which is a key transcription fac-
tor responsible for regulating fatty acid and cholesterol
biosynthesis, as wall as lipogenic gene expression includ-
ing fatty acid synthase (FAS) and acetyl Co-A carboxy-
lase in mice. It is of interest that glucose feeding could
induce, via insulin stimulation, a short-term peak induc-
tion of SREB, whereas fructose caused gradual increas-
ing of SREBP-1c activity, providing evidence that
lipogenesis can be independent of insulin control, but
may depend on carbohydrate availability [81].
Other studies dealing with the effect of high fructose
feeding on mitochondrial and peroxisomal b-oxidation
found that fructose has been implicated in reducing
PPARa in rat hepatocytes. Eight weeks of a high fruc-
tose diet induced a decrease in PPARa,w h i c hi sa
ligand activated nuclear hormone receptor responsible
for inducing mitochondrial and peroxisomal b-oxidation
[82]. Therefore, fructose might induce hepatic cellular
lipid accumulation due to decreased lipid oxidation fol-
lowing reducing PPARa.
Of interest, lipid accumulation in fructose-fed rodents
has been suggested to be through intestinal flora.
Recently, it has been shown the dietary alteration of
intestinal flora increased levels of plasma lipopolysac-
charides (endotoxin). Fructose fed mice were found to
produce endotoxinemia and fatty liver that could be
prevented with antibiotic treatment [83], suggesting a
bacterial origin of fructose induced fatty liver.
Adiposity and fat storage in adipose tissue
Indeed high fructose feeding has been found to cause an
increase in adiposity. High dietary fructose intake and
increasing body adiposity is clearly linked in both rats
submitted to 57% dietary fructose [69,84,85] and in
mice consuming fructose containing soft drinks (HFCS,
15%, 61 Kcal/100ml, 52 g/day) [86]. The increased adi-
pose tissue mass in 3 or 6 week-fructose fed rats has
been attributed in part to decreased isoproterenol-sti-
mulated lipolysis and to the increased antilipolytic
action of insulin [69]. Lipogenesis in rats, however, is
found to be shifted to the liver because fructose feeding:
1. activates lipogenic enzymes such as fatty acid
synthase and malic enzyme in the liver but not in the
adipose tissue [72,87], and 2. depresses conversion of
glucose to lipids in adipose tissue [13,87,88]. Neverthe-
less, a recent study demonstrated that very long periods
(6 months) on HFCS might increase adipose tissue fat
in Sprague Dawley rats [89].
Similarly, intracellular lipid accumulation in the cyto-
plasm of muscle fibres has been demonstrated after sev-
eral weeks of high sucrose diet, not a pure fructose diet,
leading to insulin resistance [90].
Therefore, in animals a high fructose diet induces
lipogenesis mainly in the liver or muscle fibers but not
in the adipose tissue. However the increased adiposity in
adipose tissue would most likely be due to decreased
lipid mobilization. Various mechanisms were implicated.
These results were induced with high doses of fructose
either as dietary fructose or as drinks; and therefore,
these effects in rodents could no be extrapolated to
effects with physiologically significant amounts in
humans.
Acute studies in humans
In an attempt to understand the mechanisms involved
in fructose-induced hypertriglyceridemia and its contri-
bution to de novo lipogenesis in an acute setting, in
humans, the group of Frayn [91] used a high dose of
fructose 0.75g/Kg body weight in a liquid breakfast of
mixed macronutrients. [2H2] Palmitate and [U13 C]
fructose or [U13 C] glucose were added to trace the
handling of dietary fats and the fate of dietary sugars in
the body. Compared with glucose, fructose consumed
with the fat-containing liquid increased the 4-h appear-
ance of the meal’s fatty acid in VLDL. They found, how-
ever, that the large amount of fructose used led to
impaired triacylglycerol clearance rather than contribut-
ing to de novo lipogenesis.
In addition, Parks and co-workers [7] aimed to deter-
mine the magnitude by which acute consumption of
fructose in a morning bolus would further increase TG
concentrations after the next meal. Six healthy subjects
consumed carbohydrate boluses of sugar (85g each) in a
random order followed by a standard lunch 4 hours
later. Subjects consumed either a control test of glucose
(100%), a mixture of 50: 50 or 25:75 (wt:wt) glucose:
fructose. The investigators demonstrated that post meal
lipogenesis increased in proportion to fructose concen-
tration in a beverage: from 7.8% for 100g glucose bever-
age to 15.9% after a mixture of 50g glucose: 50g
fructose and 16.9% after a mixture of 25g glucose: 75g
fructose beverage. Body fat synthesis was measured
immediately after the sweet drinks were consumed. This
study concluded that fructose has an immediate acute
lipogenic effect; with greater serum TG level in the
morning, and after a subsequent meal, even if consumed
as a small amount in a mixture of sugars. The small
amount was either 50g or 75g taken with glucose in a
beverage. However, it is misleading to suggest that the
consumption of a specific food or food ingredient was
t h ec a u s eo fo b e s i t ya n dt h er i s eo fT y p e2d i a b e t e s .
Similar results with high fructose-sweetened beverages
showed an immediate increase of acute 24-hour TG in
obese men and women [92].
On the other hand, the fate of fructose may be its oxi-
dation and not only TG accumulation. Using an oral
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et al [93] reported that 56% or 59% of fructose load was
oxidized over 6-h study. Again, a very high dose of fruc-
tose was used to examine this pathway.
The studies cited above used high amounts of fructose
with or without labeled fructose to induce hypertrigly-
ceridemia in an acute setting to evaluate underlying
mechanisms. We can not draw negative conclusions
about moderate amounts of fructose as the cause of
obesity epidemic from these studies.
Chronic studies in humans
Swarbrick et al [94], evaluated the metabolic effect of 10
week consumption of fructose-sweetened beverages
(25% of total carbohydrates). The authors demonstrated
that the consumption of fructose-sweetened beverages
increased postprandial TG and fasting apo B concentra-
tion. They suggested that long-term consumption of
diets high in fructose could lead to an increased risk of
cardiovascular diseases. Nevertheless, the conclusion
was drawn after a study undertaken in only 7 over-
weight or obese postmenopausal women with special
metabolism and a special type of adiposity. Limitations
of this study are mainly due to the substantial variations
of postprandial TG, (see Figure 2-A). The presented
SEMs are great with expected high and overlapping SD
values. Moreover, this study in one group consuming
fructose sweetened beverages lacks comparison with
another group consuming sucrose sweetened beverages.
Later, the same group [23] using a similar protocol,
but in a group of overweight/obese subjects (16 men
and 16 women), compared the effect of glucose to that
Figure 2 Postprandial TG responses to fructose- and glucose sweetened beverage consumption. A. Changes of the area under the curve
over 14 h sampling periods before and after 2 and 10 weeks of consuming fructose sweetened beverages at 25% of daily energy in 7
overweight or obese postmenopausal women, values are means ± SE, * :p < 0.05 vs 0wk (figure adapted from Swarbrick et al (94)). B. Mean 24
hour TG and C. TG AUCs (23 h) before and after 2, 8 and 10 week consumption of glucose or fructose-sweetened beverages at 25% of daily
energy intake in overweight/obese humans (G=glucose group: n= 14; F= fructose group: n= 17); values are means ± SEM, * :p < 0.05 vs 0wk in
the fructose group (figures adapted from Stanhope et al [23]).
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energy requirements for 10 weeks in overweight and
obese subjects on visceral adiposity, plasma lipids and
insulin sensitivity. The carbohydrate intake of these sub-
jects was 25% from sweetened beverages and 30% com-
plex carbohydrates. This means that fructose or glucose
represented half of the provided carbohydrates; as men-
tioned in the study: this amount was higher than 15.8%
(the current estimate for the mean intake of total added
sugars by Americans [95]). The authors evaluated the
effect of the sweetened beverages with an ad libitum
diet, meaning that subjects could eat as much as they
want without any special recommendation or counseling
concerning food intake. As expected both groups exhib-
ited significant increase in body weight, fat mass, and
waist circumference, without any difference between the
two groups. The authors said that visceral adipose
volume was significantly increased only in subjects con-
suming the fructose-sweetened beverages. However, it
was not clear how total visceral adipose tissue was mea-
s u r e d .T h ea u t h o r sc i t e dt h a tt h e yh a dd o n eaC Ts c a n
at the umbilicus level. This means that this was in a one
cross section at one level. Moreover, even by DEXA
measurements (Dual energy X-ray absorptiometry) visc-
eral or subcutaneous adipose tissue could not be esti-
mated precisely. Therefore, it is misleading to say that
in such a study visceral fat is increased by fructose-
sweetened beverages. On the other hand, it is not sur-
prising that high amounts of fructose might induce
postprandial hypertriglyceridemia as well as increase
fasting LDL and apo B. The limitation of this study is
the great variations in the SEM presented (figure 2B and
2C). In addition, while it is true that fructose consump-
tion increased the 23-hour postprandial TG AUC as
well as the mean 24h TG compared to results before
fructose consumption, there was no significant differ-
ence between glucose- and fructose-sweetened beverage
consumptions (Figure2B and 2C).
Havel et al [92] demonstrated later that the increase in
TG excursions during 24 hours (Area under curve) of
fructose beverages depends mainly on the degree of
insulin resistance of obese subjects.
Recently, Lê et al [96] found that a 7-day hypercaloric
high-fructose diet (3.5 g fructose/kg/day, +35% energy
intakes) increased ectopic lipid deposition in liver and
muscle and fasting VLDL-TG as could be expected with
these high amounts. The alteration in plasma lipids was
more pronounced in a group of healthy offspring of
patients with type 2 diabetes, who might be more sus-
ceptible to developing lipid alterations when subjected
to high fructose intake. This is in agreement with the
finding of the same group in 7 healthy men [22] demon-
strating that four weeks of a high fructose diet contain-
ing 1.5 g fructose/kg body weight/day increased plasma
TG but without causing liver or muscle lipid deposition
or insulin resistance in these healthy subjects.
One of the effects of fructose intake is a suppression
of plasma free fatty acids, which suggests an inhibition
of adipose tissue lipolysis [97]. While this has been con-
firmed in rats on isolated adipocytes [69], the same
effect has been shown in healthy subjects after 7 days
on a high fructose diet [98].
In humans, in acute as well as in chronic studies, high
(>15% Energy, more than 50g/day), fructose feeding has
been found to elevate daylong serum triglycerides in
healthy subjects ([17], [99-102]103), diabetic patients
[104] and overweight/obese subjects [23,105]. Evidence
exist that the elevated postprandial triglyceride levels as
well as lipid deposition in liver and muscle depend on
insulin resistant status of the subjects.
Epidemiological Studies
In a longitudinal study Fung et al [106] found that
women who drink two or more servings of sweetened
beverages per day may increase their risk of heart dis-
ease by 35 per cent. The study evaluated data from
88,520 women 34 to 59 years old participating in the
Nurses’ Health Study. The women were free of coronary
heart disease or diabetes at the end of the study in
1980. Seven food-frequency questionnaires between
1980 and 2002 were used to evaluate dietary habits.
While in this study subjects were put on all sweetened
beverages. The authors accused fructose, since it had
been the major sweetener in the sugar sweetened bev-
erages. However, none of the observational data were
able to establish causality.
While most studies have been conducted in adults,
rare studies have been done in children.
Studying normal-weight and overweight 6-14 old
Swiss children, Aeberli et al [4] aimed to determine
whether LDL particle size is associated with dietary fac-
tors and especially with fructose intake. The authors
used a cross-sectional, and not interventional, study in
74 children and dietary intakes were estimated by using
two 24-h recalls and a one-day dietary record. Although
there were no significant differences in total fructose
intake, the authors concluded that after adjusting the
results for adiposity, fructose intake was a significant
predictor of LDL particle size, which was significantly
s m a l l e ri nt h eo v e r w e i g h tc h i l d r e nt h a ni nt h en o r m a l
weight ones. However, upon further examination, these
values (Figure 3), the LDL particle size, while described
as statistically different, could not have significant clini-
cal impact with only a 1.7% reduction between the two
groups with overlapping of values (great SD). This study
gave quite a negative image of fructose and reopened
the debate on whether fructose consumption itself was
a health risk. Again it must be noted that this was a
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based on dietary recalls or dietary records. Dietary
recalls, even when validated, can not give precise
results, particularly in children, because their ability to
record or remember their diet is limited [107,108]. In
this study there was no association between fructose
consumption and HDL, LDL, total cholesterol or tria-
cylglycerol. The study failed to demonstrate an increase
in total fructose intake in the overweight children. How-
ever, the authors cited that overweight children con-
sumed significantly less fructose, as a percentage of
total fructose, from fruits and vegetables but more fruc-
tose, also as a percentage of total fructose, from swee-
tened drinks and sweets. This is some what misleading,
because the absolute amounts of fructose intake from
fruits and vegetables or from sweet drinks did not differ
significantly between the two groups. In addition, the
correlation between LDL size and total fructose intake
was poor, b = - 0.245. This poor correlation, however,
could not confirm a causal relationship. In a debate
entitled “Fructose: Sweet or Bitter for Diabetes” that
took place during the 26th Symposium on Diabetes and
Nutrition Study Group (DNSG, 2008, Varna, Bulgaria)
of the EASD, the author (Dr Isabelle Aeberli) admitted
that the problem with fructose is due mainly to the
amount utilized and not to fructose itself. Moreover,
the generation of small triacylglycerol rich lipoprotein
particles, such as generated by fructose, does not itself
seem to be a sufficient condition for atherogenesis
[109].
Meta analysis
In a recent meta-analysis Livesey and Taylor [40] exam-
ined 60 studies looking at the link between fructose
intake on fasting plasma TG and 25 studies dealing with
the effect of fructose on postprandial plasma TG in
humans. This meta-analysis included different types of
subjects: healthy, with impaired fasting glucose, impaired
glucose tolerance, type 2 diabetes, subjects with elevated
risk of coronary heart disease, and subjects with any
form of hyperlipidemia. The authors found that fructose
intake < 50 g/d had no significant effect on triacylgly-
cerol post- prandially and ≤ 100g/d had no significant
effect on fasting levels but was associated with increased
postprandial TG excursions. Consumption of 50 g fruc-
tose per day for up to 2 years is without effect on fast-
ing plasma triacylglycerol in healthy individuals [110].
At a daily fructose dose >100g, the effect on fasting tria-
cylglycerol depended on whether sucrose or starch was
being exchanged with fructose. This effect was dose
dependent, and was lower with increasing the duration
of treatment. Different health types and sources of bias
were examined showing no significant departure from a
general trend.
In another meta-analysis, a Canadian group evaluated
the differential effects of isocaloric exchange of fructose
for other carbohydrates on triglycerides in peoples with
diabetes [111]. They selected 14 papers meeting their
criteria out of a total of 725 papers. There was no signif-
icant effect of the isocaloice x c h a n g eo ff r u c t o s ef o r
CHO on TG with strong heterogeneity. In a further ana-
lysis separating patients with type 2 diabetes from those
with type 1 diabetes, fructose was found to increase tri-
glycerides in type-2 but not type-1 diabetes. This effect
could be detected when high doses of fructose was
taken (>65g/d) during short- term (≤4 weeks) and when
fructose substituted starch [112,113] but not sucrose
[114-116]. Moderate fructose consumption (<50 g/d, or
~10% of metabolizable energy intake) has previously
been considered acceptable in diabetics [109,117,118].
Therefore, < 50g/day added fructose by day has no
deleterious effect on both fasting and postprandial
triglycerides.
Fructose and insulin resistance
Evidence from experimental studies in animals
T h e r ei sm u c he v i d e n c ei na n i m a lm o d e l ss u p p o r t i n g
the notion that fructose when consumed in high
amounts contributes to hepatic and peripheral insulin
resistance [70,71,119,120]. In rats fed a fructose- rich
diet Thorburn et al [120], using the hyperinsulinemic
euglycemic clamp method, demonstrated lower insulin
Figure 3 LDL particle size in 6 to 14 years old Swiss children,
values are means ± SD, (Figure adapted from Aeberli et al [4].
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pose tissues than in rats fed a dextrose rich diet.
A decrease in skeletal and hepatic insulin receptor num-
ber, determined by an in situ autoradiography techni-
que, as well as a decrease in their gene expression was
found by 66% fructose feeding for 2 weeks in rats [121].
Moreover, decreased insulin-induced insulin receptor
phosphorylation was demonstrated in the liver of fruc-
tose fed rats[122] A 57% fructose diet induced, similarly,
a decrease in insulin stimulated glucose incorporation
into lipids but increased the antilipolytic action of insu-
lin in isolated adipocytes of normal rats [13,69].
Three weeks of a 10% fructose-rich diet [123] induced
adaptive changes in islets of rats: decreased b-cell mass
with increasing apoptotic cells, increased glucose-
induced insulin release and islet glucose metabolism,
increased glucokinase, but not hexokinase activity.
These modifications resulted in an increase of insulin
release in spite of marked b-cell mass reduction leading
to hyper insulinemia, impaired glucose tolerance and
insulin resistance.
Here again, the high fructose fed rats used as a model
of insulin resistance to evaluate the islet adaptive
changes in such situations (peoples at risk of developing
type 2 diabetes). Recently, the group of Havel [124] has
demonstrated that 4 months of sustained fructose con-
sumption (20% of energy) accelerate the onset of type 2
diabetes in a model of pylogenic obese type 2 diabetic
rats. The presence of an antioxidant with insulin sensi-
tizing activity ameliorates the effect of fructose by
improving glucose homeostasis, which is likely due to
preserving b-cell function.
Moreover, fructose-fed rats demonstrated a defect in
neural insulin signaling pathway in the brain. Decreased
insulin stimulated-tyrosine phosphorylation of insulin
receptors and insulin receptor substrate 1 (IRS-1) were
demonstrated in the fructose-fed hamsters [125]. Also
insulin-mediated phosphorylation of residues necessary
for activation of another key effector of insulin signalling
was markedly decreased.
Nevertheless, high fructose-fed rat model is often used
in many studies as a dietary model of insulin resistance
[15,126,127]. In rodents, therefore, there is no doubt
that high-fructose feeding cause insulin resistance.
Acute Studies in Humans
In humans, hardly any evidence exists to confirm
directly the negative effects of fructose on insulin sensi-
tivity. Fructose has been considered as a therapeutic
tool in the diet of diabetic patients due to its low glyce-
mic index [128] and because it’s initial metabolic steps
do not need insulin [79]. It elicits an increase in energy
expenditure that has been suggested to be beneficial for
obese subjects with or without diabetes [97,129]. The
effect of fructose infusion on hepatic insulin sensitivity
in conditions of moderate hyperglycaemia has been stu-
died during hyperglycaemic clamp study with or without
infusion of 16.7 μmol/kg/min fructose [130]. The acute
fructose infusion induced both extra hepatic and hepatic
insulin resistance, which has been suggested to be sec-
ondary to an increased intrahepatic glucose 6-phosphate
synthesis. These results raise questions as to whether
ingested fructose as part of the diet may have the same
effects.
Chronic studies in humans
Consuming an extra 1000 Kcal as fructose, which is a
high amount, for one week induced a reduction in both
insulin binding and insulin sensitivity when compared
to effects after the same amount of glucose in young
healthy subjects [131]. In a special case, the presence of
f r u c t o s ea st h eu n i q u es o u r c eo fc a r b o h y d r a t ei nav e r y
low calorie diet (600 Kcal) postponed by two weeks the
expected amelioration of a low calorie diet for plasma
glucose and insulin levels as well as insulin binding
[132].
Moderate fructose intake (1/3 carbohydrate intake),
however, in healthy subjects for 2 weeks has no deleter-
ious effect on insulin sensitivity compared to the same
amount of sucrose [133,134].
In healthy subjects, consuming up to1.5 g fructose/kg
body weight per day for 4 weeks increased plasma trigly-
cerides but without inducing insulin resistance [135].
The authors of the latter study were able, however, to
detect early molecular alterations in only two skeletal
muscle genes. They suggested, therefore, that these
alterations could induce later whole body insulin resis-
tance [135]. The same group showed that fructose over-
feeding (3.5 g fructose/kg fat-free mass/day, again a high
dose) for 6 days produces hepatic insulin resistance in
men, whereas these effects are markedly blunted in
healthy young men[136].
In diabetic subjects, other chronic studies could not
detect any deleterious effects of moderate fructose
intakes: 30 g fructose/day compared to starch as a part
of 1400 - 1600 Kcal for 8 weeks [112], or one year [137]
or 60g fructose/day for 12 weeks, [138] or 6 months
[139].
Using high amount of fructose, however, as fructose-
sweetened beverages at 25% of energy requirements for
10 weeks, led to an increase in fasting plasma glucose
and insulin levels and decreased insulin sensitivity com-
pared to the same amount of glucose sweetened bev-
erages [23].
Epidemiological studies
In a prospective large cross-sectional study -Nurses
Healthy Study I and II- an association was found
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concentrations [140]. Due to this association, the
authors suggested that fructose intake may play a role in
the development of insulin resistance and type 2 dia-
betes. However, causal relationship could not be identi-
fied from this study design.
In a longitudinal study, Janket et al [141] evaluated the
relationship between risk of type 2 diabetes and intakes
of total caloric sweeteners, sucrose, fructose, glucose
and lactose in a cohort of 38,480 female health profes-
sionals. Neither fructose, glucose nor sucrose was
related to the risk of developing type 2 diabetes. There-
fore, no difference could be detected between the differ-
ent sugars.
While some investigators are able to detect deleterious
effects with high doses or could not detect with moder-
ate doses, others found beneficial effects. Koivisto et al
[113] demonstrated that the substitution of moderate
amounts of fructose (45-65 g/day: 20% of carbohydrate
calories) for complex carbohydrates for 4 weeks
improves insulin sensitivity in type 2 diabetic patients.
Similarly Reiser et al [102] found that patients adapted
to 20% of energy as fructose for 5 weeks had improved
plasma glucose responses to a glucose charge compared
to a group adapted to starch diet. In a group of children
with diabetes 1g fructose/kg/day (30g/day maximum)
with guar gum for three weeks was found to decrease
HBA1c but with increased glucoseuria [142].
In small doses, however, dietary fructose appears to be
beneficial in enhancing glucose tolerance [143,144]. The
addition of small doses of fructose to a glucose meal
can enhance hepatic glucose disposal. Moreover, the
addition of small amounts of fructose to orally ingested
glucose increases hepatic glycogen synthesis and reduces
glycemic responses in subjects with type 2 diabetes
[145]. This effect was found to be due to a rise in Fruc-
tose-1-P which has an important indirect effect on hepa-
tic glucose metabolism by modulating glucokinase
activity which is a key regulatory enzyme required for
the formation of glucose -6-P. Glucokinase also is
involved in the inhibition of hepatic glucose release by
portal hyperglycemia [146]. Fructose-1-P, at low levels
antagonizes a glucokinase regulatory protein, enhancing,
then, glucokinase activity. Stimulation of hepatic glyco-
gen synthesis by this mechanism may be of potential
therapeutic value. However, high doses could be
deleterious.
Recently, a meta-analysis [40] demonstrated that fruc-
tose intakes from 0 to ≥ 90g/d have a beneficial effect
on HbA1c. This meta-analysis was done on a group of
studies in healthy, glucose intolerant and type-2 dia-
betes. The authors, however, are aware that 50 to 100g
is a high fructose intake that could affect postprandial
triglycerides. Whether a lowering or maintaining of low
H b A 1 cw i t ht h e s ed o s e so ff r u c t o s ew o u l dp e r s i s ti s
unknown. We could conclude that moderate fructose
consumption (<50 g/d, or >10%ME) appears acceptable
and potentially beneficial.
Fructose ingestion acutely elevates blood
pressure
B r o w na n dc o - w o r k e r s[ 1 4 7 ]s h o w e dr e c e n t l yt h a tt h e
acute ingestion of both glucose and fructose drinks (60 g)
brings about specific hemodynamic responses. Fructose,
in particular elicits an increase in blood pressure that
c o u l db ep r o b a b l ym e d i a t e db ya ni n c r e a s ei nc a r d i a c
output without compensatory peripheral vasodilatation.
While fructose-induced hypertension is well demon-
strated in rodents via various mechanisms [148], in
humans long-term demonstration failed. In the Nurses’
Health Study, fructose intake was not associated to the
risk for developing hypertension [149]. Moreover,
recently [136] in a chronic study using high fructose
amount of 1.5 g/kg body weight by day for 4 weeks,
there was no significant change in mean blood pressure
at the end of four week-fructose diets. There is no exist-
ing evidence for the relation between fructose and
hypertension in humans.
Fructose consumption and the risk of gout in
humans
Prospective data has suggested that consumption of
sugar sweetened soft drinks and fructose is strongly
associated with an increased risk of gout in men [150].
They concluded that other contributors to fructose
intake such as total fruit juice or fructose rich fruits
(apples and oranges) were also associated with high risk
of gout. In these studies information was provided on
intake of soft drinks and fructose through validated food
frequency questionnaires. These studies could not con-
firm a cause and effect relationship. When comparing 5
weeks of fructose consumption to 5 weeks of that of
starch (20% of energy), serum uric acid increased with
fructose intake [102]. The authors compared a simple
sugar to a complex one; therefore, these findings could
be simply due to the effect of a refined sugar. This
hypothesis is likely, because when comparing 24% of
carbohydrates consumed as fructose to that amount
consumed as sucrose, no alteration in uric acid level
was detected [151]. On the other-hand when a high
fructose amount 250-290g/d was taken for 12 days an
increase in both plasma and urinary uric acid was found
[152]. Others believe that fructose-induced hyperuricae-
mia occurs mainly in gouty patients [153].
Fructose and Exercise
Substrate utilization during exercise with glucose and
glucose plus fructose ingestion has been an important
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exogenous fructose has delayed the rate of intestinal
absorption [154], lowering the rate of oxidation during
exercise [155,156] possibly as a result of its slower
absorption rate and the necessity for its conversion to
glucose by the liver before oxidation [156]. The combi-
nation of fructose and glucose, however, is well
absorbed during exercise [157] and may facilitate a
higher oxidation than either of the two sugars ingested
separately [158]. The ingestion of glucose alone and
glucose plus fructose delays exhaustion at 90% peak
power by 25 and 40% after 90 minutes of moderate-
intensity exercise [159]. While pre-exercise and exer-
cise ingestion of glucose and fructose are of equal
values in delaying exhaustion, ingestion of fructose
b e f o r ea n dd u r i n gt h ee x e r c i s ep r o v i d eam o r ec o n -
stant supply of available glucose to the working muscle
[160].
Other beneficial effects
Dietary fructose (20% of the calories from fructose)
enhances mineral balance [161]. Another effect is that
the intake of 250 ml of a drink rich in fructose after
alcohol consumption will decrease the plasma alcohol
levels by 10% [162].
Conclusions
Certainly high fructose consumption can induce insulin
resistance, impaired glucose tolerance, hyperinsulinemia,
hypertriglyceridemia, and hypertension in animal mod-
els. There is no evidence for similar effects in humans
at realistic consumption patterns. Although there are
existing data on the metabolic and endocrine effects of
dietary fructose that suggest that increased consumption
of fructose may be detrimental in terms of body weight
and adiposity and the metabolic indexes associated with
the insulin resistance syndrome, much more research is
needed to fully understand the metabolic effect of diet-
ary fructose in humans. Despite the epidemiological par-
allel between the marked increase of obesity and
fructose consumption, there is no direct evidence link-
ing obesity to the consumption of physiological amounts
of fructose in humans (≤ 100g/day). A moderate dose
(≤ 50 g/day) of added fructose has no deleterious effect
on fasting and postprandial triglycerides, glucose control
and insulin resistance. There is no existing evidence for
a relation between moderate fructose consumption and
hypertension. Fructose may induce hyperuricaemia, but
mainly in patients with gout.
Beneficial effects of moderate amounts of fructose
have also been demonstrated: 1. Fructose seems to
decrease appetite when taken in a solution or puddings
before a meal, 2. It seems to lower plasma glucose
responses to orally ingested glucose via stimulation of
hepatic glycogen, when added to the glucose challenge,
3. While pre-exercise and exercise ingestion of glucose
and fructose are of equal values in delaying exhaustion,
ingestion of fructose before and during the exercise pro-
v i d eam o r ec o n s t a n ts u p p l yo fa v a i l a b l eg l u c o s et ot h e
working muscle.
Two new reviews were published during the revision
of this manuscript that strengthen our conclusions: The
first is an evidence-based review [163] indicating that
fructose does not cause biologically relevant changes in
TG or body weight when consumed at levels approach-
ing 95th percentile estimates of intake. This review is
based on recent guidance developed by the US Food
and Drug Administration (FDA) [164]. The second
review by Tappy and Lê [37] concluded that: 1) there is
no unequivocal evidence that fructose intake at moder-
ate doses is directly related with adverse events in man;
2) there is no direct evidence for more serious metabolic
consequences of high fructose corn syrup versus sucrose
consumption.
The implications of any balance of effects of fructose
on different aspects of metabolism in terms of possible
risk to health would need to be ascertained using more
direct long-term intervention studies.
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